#United States #Johnson & Johnson #Irvine #SOUNDSTAR CRYSTAL #CARTO 3 System

Introduction

On May 21, 2025, Johnson & Johnson MedTech, a prominent player in the cardiac arrhythmia treatment sector, announced the launch of its latest innovation, the SOUNDSTAR CRYSTAL™ Ultrasound Catheter, aimed at improving the quality of intracardiac echocardiography (ICE) imaging for cardiac ablation procedures in the United States. This state-of-the-art catheter signifies a major advancement in imaging technology, providing enhanced clarity and precision during critical procedures.

Enhanced Imaging Technology

The SOUNDSTAR CRYSTAL™ stands out among existing ICE catheters by delivering superior image quality, enabling healthcare professionals to visualize fine anatomical details within the heart accurately. With an advanced 88-element phased linear array, the device not only enhances image clarity but also improves maneuverability, making it a vital tool for electrophysiologists conducting ablation procedures.

Integration with CARTO™ 3 System

One of the most significant features of the SOUNDSTAR CRYSTAL™ is its seamless integration with the CARTO™ 3 Mapping System. This integration is further enhanced by the CARTOSOUND™ FAM module, which employs advanced artificial intelligence algorithms to facilitate the automatic generation of left atrial anatomy. This functionality simplifies the workflow for clinicians, allowing for a more streamlined approach during procedures.

Jasmina Brooks, President of Electrophysiology at Johnson & Johnson MedTech, emphasized the importance of this innovation, stating, "We are proud to advance our legacy in integrated ultrasound catheters with this latest innovation that equips electrophysiologists with the tools they need to promote patient safety and drive effective results." This assertion speaks volumes about the commitment of Johnson & Johnson MedTech to enhance patient care and safety.

Benefits for Healthcare Professionals

The SOUNDSTAR CRYSTAL™ Ultrasound Catheter is designed for optimal balance between stiffness and flexibility, crucial for ensuring precision during maneuverability. Such design considerations help achieve a zero fluoroscopy workflow, significantly enhancing both procedure effectiveness and safety for patients and healthcare professionals alike.

Real-time imaging plays a critical role in catheter ablation, allowing clinicians to visualize catheter-tissue interaction and monitor ablation in real-time. When used in conjunction with a 3D electroanatomical mapping system like CARTO™ 3, ICE can reconstruct cardiac anatomy and aid in performing zero-fluoroscopy procedures, further minimizing patient exposure to potentially harmful radiation.

Dr. Amin Al-Ahmad of St. David's HealthCare in Austin, Texas, shared insights from his experience using the SOUNDSTAR CRYSTAL™, highlighting the clear visualization and enhanced imaging capabilities that significantly improve the mapping process and overall workflow during ablation procedures.

Addressing Cardiac Arrhythmias

Cardiac arrhythmias, especially atrial fibrillation (AFib), affect millions worldwide, making innovations like the SOUNDSTAR CRYSTAL™ critical in the battle against heart diseases. AFib is a progressive condition that can lead to severe complications like stroke and heart failure if left untreated. Catheter ablation has been identified as a safe and effective method to restore the heart's normal electrical signals.

By providing advancements in 2D ICE technology, Johnson & Johnson MedTech contributes to addressing healthcare professionals' ongoing challenges in treating cardiac arrhythmias—reinforcing the company's commitment to improving patient outcomes.

Conclusion

As the healthcare landscape continuously evolves, innovations like the SOUNDSTAR CRYSTAL™ Ultrasound Catheter demonstrate Johnson & Johnson MedTech's leadership in developing cutting-edge solutions that prioritize patient safety and procedure efficacy. With features that enhance image clarity and a design that simplifies workflows, this new technology is set to redefine the standards in intracardiac imaging, ultimately benefiting both patients and clinicians.

To learn more about Johnson & Johnson MedTech and its exciting portfolio of cardiac solutions, visit Biosense Webster.